Chemicals Q2 2021 Sales1 in the Chemicals segment rose considerably compared with the prior-year quarter, especially in the Petrochemicals division. (XLSX:) XLS Factors influencing sales in Q2 2021 – Chemicals Chemicals Petrochemicals Intermediates Volumes 20% 19% 22% Prices 78% 100% 37% Portfolio 0% –1% 0% Currencies –7% –8% –5% Sales 91% 110% 54% The sales increase was primarily due to significantly higher price levels, owing largely to strong demand alongside lower product availability. The Petrochemicals division increased prices significantly, in particular for cracker products, styrene monomers and acrylic monomers. Price levels also rose considerably in the Intermediates division, mainly in the butanediol and derivatives as well as in the acids and polyalcohols businesses. Significantly higher volumes had a positive impact on sales in both divisions. The segment’s sales volumes had been heavily burdened by the effects of the coronavirus pandemic in the prior-year quarter. Volumes in the Petrochemicals division were higher, especially for styrene monomers, acrylic monomers and cracker products, while the Intermediates division increased volumes particularly in the butanediol and derivatives and in the acids and polyalcohols businesses. Negative currency effects, mainly relating to the U.S. dollar, had an offsetting effect. Income from operations (EBIT) before special items1 was considerably above the second quarter of 2020. This was largely attributed to considerably higher EBIT before special items in the Petrochemicals division, which resulted mainly from increased margins, greater sales volumes as well as a considerable improvement in income from equity-accounted companies. In the prior-year quarter, apart from the effects of the coronavirus pandemic, the division’s earnings had also been negatively impacted by scheduled turnarounds in Nanjing, China. EBIT before special items also rose considerably in the Intermediates division. This was due primarily to higher margins in the butanediol and derivatives business, improved income from equity-accounted companies and lower fixed costs. 1 For sales, “slight” represents a change of 1%–5%, while “considerable” applies to changes of 6% and higher. “At prior-year level” indicates no change (+/–0%). For earnings, “slight” means a change of 1%–10%, while “considerable” is used for changes of 11% and higher. “At prior-year level” indicates no change (+/–0%). (XLSX:) XLS Segment data – Chemicals (Million €) Q2 H1 2021 2020 +/– 2021 2020 +/– Sales to third parties 3,419 1,791 91% 6,155 4,141 49% of which Petrochemicals 2,467 1,173 110% 4,404 2,812 57% Intermediates 952 618 54% 1,751 1,329 32% Income from operations before depreciation, amortization and special items 1,168 216 441% 1,905 607 214% Income from operations before depreciation and amortization (EBITDA) 1,162 210 453% 1,946 596 227% Depreciation and amortizationa 181 228 –21% 360 444 –19% Income from operations (EBIT) 981 –18 . 1,586 152 . Special items –9 –16 44% 38 –20 . EBIT before special items 990 –2 . 1,548 172 . Assets (June 30) 8,971 8,642 4% 8,971 8,642 4% Investments including acquisitionsb 243 153 59% 371 513 –28% Research and development expenses 25 24 4% 51 49 4% a Depreciation and amortization of property, plant and equipment and intangible assets (including impairments and reversals of impairments) b Additions to property, plant and equipment and intangible assets back next